Cargando…

Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease

This review gives a brief insight into the role of mitochondrial dysfunction and oxidative stress in the converging pathogenic processes involved in Parkinson's disease (PD). Mitochondria provide cellular energy in the form of ATP via oxidative phosphorylation, but as an integral part of this p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Philip WL, Ho, Jessica WM, Liu, Hui-Fang, So, Danny HF, Tse, Zero HM, Chan, Koon-Ho, Ramsden, David B, Ho, Shu-Leong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506996/ https://www.ncbi.nlm.nih.gov/pubmed/23210978 http://dx.doi.org/10.1186/2047-9158-1-3

Ejemplares similares

Human neuronal uncoupling proteins 4 and 5 (UCP4 and UCP5): structural properties, regulation, and physiological role in protection against oxidative stress and mitochondrial dysfunction
por: Ramsden, David B, et al.
Publicado: (2012)

Uncoupling Protein-4 (UCP4) Increases ATP Supply by Interacting with Mitochondrial Complex II in Neuroblastoma Cells
por: Ho, Philip Wing-Lok, et al.
Publicado: (2012)

Mitochondrial Uncoupling Protein-2 (UCP2) Mediates Leptin Protection Against MPP(+) Toxicity in Neuronal Cells
por: Ho, Philip Wing-Lok, et al.
Publicado: (2009)

Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease
por: Teo, Kay Cheong, et al.
Publicado: (2013)

Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays
por: Chan, Koon H, et al.
Publicado: (2010)

The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease
por: Pang, Shirley Yin-Yu, et al.
Publicado: (2019)

Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease
por: Lim, L, et al.
Publicado: (2012)

Assessment of Cellular Estrogenic Activity Based on Estrogen Receptor-Mediated Reduction of Soluble-Form Catechol-O-Methyltransferase (COMT) Expression in an ELISA-Based System
por: Ho, Philip Wing-Lok, et al.
Publicado: (2013)

LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
por: Chang, Eunice Eun Seo, et al.
Publicado: (2022)

Antioxidants inhibit neuronal toxicity in Parkinson's disease‐linked LRRK2
por: Angeles, Dario C., et al.
Publicado: (2016)

Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease
por: Liu, Hui-Fang, et al.
Publicado: (2017)

LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
por: Pang, Shirley Yin-Yu, et al.
Publicado: (2022)

The mitochondrial uncoupling proteins
por: Ledesma, Amalia, et al.
Publicado: (2002)

Uncoupling Protein 2 in Cardiovascular Health and Disease
por: Tian, Xiao Yu, et al.
Publicado: (2018)

Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease
por: Chouhan, Amit K., et al.
Publicado: (2016)

PMCA4 (ATP2B4) Mutation in Familial Spastic Paraplegia
por: Li, Miaoxin, et al.
Publicado: (2014)

PMCA4 (ATP2B4) mutation in familial spastic paraplegia causes delay in intracellular calcium extrusion
por: Ho, Philip Wing-Lok, et al.
Publicado: (2015)

Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle
por: Malkus, Kristen A, et al.
Publicado: (2009)

Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA)
por: Ho, Philip Wing-Lok, et al.
Publicado: (2019)

In vivo overexpression of synaptogyrin‐3 promotes striatal synaptic dopamine uptake in LRRK2(R1441G) mutant mouse model of Parkinson's disease
por: Ho, Philip Wing‐Lok, et al.
Publicado: (2023)

Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases
por: Demine, Stéphane, et al.
Publicado: (2019)

Nitro-Deficient Niclosamide Confers Reduced Genotoxicity and Retains Mitochondrial Uncoupling Activity for Cancer Therapy
por: Ngai, Tsz Wai, et al.
Publicado: (2021)

Uncoupling Transcription from Covalent Histone Modification
por: Zhang, Hesheng, et al.
Publicado: (2014)

Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
por: Yi, Shuanglong, et al.
Publicado: (2022)

Mitochondrial uncoupling proteins and energy metabolism
por: Busiello, Rosa A., et al.
Publicado: (2015)

Circadian regulation of mitochondrial uncoupling and lifespan
por: Ulgherait, Matt, et al.
Publicado: (2020)

Circadian Regulation of Mitochondrial Uncoupling and Lifespan
por: Ulgherait, Matthew
Publicado: (2020)

Muscle Mitochondrial Uncoupling Dismantles Neuromuscular Junction and Triggers Distal Degeneration of Motor Neurons
por: Dupuis, Luc, et al.
Publicado: (2009)

Mitochondrial homeostasis in Parkinson’s disease - a triumvirate rule?
por: Ng, Chee-Hoe, et al.
Publicado: (2017)

Uncoupling mitochondrial uncoupling from alternative substrate utilization: implications for heavy intensity exercise
por: Goulding, Richie P., et al.
Publicado: (2020)

Current Opinion on the Role of Neurogenesis in the Therapeutic Strategies for Alzheimer Disease, Parkinson Disease, and Ischemic Stroke; Considering Neuronal Voiding Function
por: Han, Myung-Hoon, et al.
Publicado: (2016)

LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity
por: Liu, Hui-Fang, et al.
Publicado: (2014)

Mitochondrial uncoupling in the melanocortin system differentially regulates NPY and POMC neurons to promote weight-loss
por: Michael, Natalie Jane, et al.
Publicado: (2017)

Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson's disease
por: Chung, Young C, et al.
Publicado: (2017)

Epigenetic modification in Parkinson’s disease
por: Song, Hao, et al.
Publicado: (2023)

0035. Mitochondrial uncoupling contributes to fever in sepsis
por: Greco, E, et al.
Publicado: (2014)

Exploring the therapeutic potential of mitochondrial uncouplers in cancer
por: Shrestha, Riya, et al.
Publicado: (2021)

Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH
por: Goedeke, Leigh, et al.
Publicado: (2021)

BAM15 as a mitochondrial uncoupler: a promising therapeutic agent for diverse diseases
por: Xiong, Guoji, et al.
Publicado: (2023)

Mitochondrial DNA Depletion in Respiratory Chain–Deficient Parkinson Disease Neurons
por: Grünewald, Anne, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0ahneplbn1uuc0j40v8d700kt1